Health Insurance - Required Coverage - Prescription Weight Loss Drugs
Maryland health insurers must cover FDA-approved prescription weight loss medications, expanding access but potentially increasing insurance costs and medication supply pressure.
Maryland health insurers must cover FDA-approved prescription weight loss medications, expanding access but potentially increasing insurance costs and medication supply pressure.
HB 1031 would require health insurance plans in Maryland to cover prescription weight loss medications as a covered benefit. The bill mandates that insurers provide coverage for FDA-approved weight loss drugs, potentially including medications like GLP-1 agonists (semaglutide, tirzepatide) that have gained significant popularity in recent years.
Prescription weight loss drugs can cost $300-$1,000+ monthly without insurance coverage, making them inaccessible to many Marylanders despite medical necessity. This bill addresses healthcare equity by ensuring coverage parity—treating obesity as a medical condition warranting insurance support, similar to coverage for diabetes or hypertension medications. The practical impact depends on whether the mandate includes cost-sharing limits and which specific drugs qualify.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.